Skip to content

Rosen, Joshua

Joshua Rosen – MD, MHS

Email:

jerosen@OBFUSCATEuw.edu

Hometown:

Toronto, Canada

Personal Interests:

Hiking, backpacking, snowshoeing, camping, reading and cooking!

Resident Bio:

I am currently in the research track in general surgery program. I am originally from Toronto and came to Seattle after medical school on the east coast. My research interest mostly are in outcomes studies and in how we can get better and more dynamic data sets to work with. In my free-time I love getting outside in the pacific northwest including hiking, backpacking, camping, and snowshoeing.

Undergraduate School:

University of Waterloo

Medical School:

Yale University

General Surgery or Preliminary Program:

Clinical Interests:

Pretty much everything at this point but I have particularly liked Thoracic Surgery , Pediatric Surgery, and Vascular Surgery so far.

Professional Activities:

Publications:

Rosen J.E., Yoffe S., Meerasa A., Verma M.S. and Gu F.X. Nanotechnology and Diagnostic Imaging: New Advances in Contrast Agent Technology. Journal of Nanomedicine & Nanotechnology. 2(5), 115, 2011.

Rosen J.E., Gu F.X. Surface Functionalization of Silica Nanoparticles with Cysteine: A Low-Fouling Zwitterionic Surface. Lanagmuir. 27(17), 10507, 2011.

Hancock J., Rosen J., Moreno A., Kim A.W., Detterbeck F.C., Boffa D.J. Management of Clinical Stage IIIA Primary Lung Cancers in the National Cancer Database. Ann Thorac Surg. 98(2) 424-432, 2014.

Rosen J.E., Hancock J.G., Kim A.W., Detterbeck F.C., Boffa D.J. Predictors of Mortality After Surgical Management of Lung Cancer in the National Cancer Database. Ann Thorac Surg. 98(6) 1953-1960, 2014.

Boffa D.J., Hancock J.G., Yao X., Goldberg S., Rosen J.E., Kim A.W., Detterbeck F.C. Now or Later: Evaluating the importance of the chemotherapy timing in resectable stage III (N2) Lung Cancer in the National Cancer Database. Ann Thorac Surg. 99(1) 200-208, 2015.

Rosen J.E., Keshava H.B., Yao X., Kim A.W., Detterbeck F.C., Boffa D.J., The natural history of operable non-small cell lung cancer in the national cancer database. Ann Thorac Surg. 101(5) 1850-1855, 2016.

Salazar M.C., Rosen J.E., Arnold B.N., Thomas D.C., Kim A.W., Detterbeck F.C., Blasberg, J.D., Boffa D.J., Adjuvant chemotherapy for T3 non-small cell lung cancer with additional tumor nodules in the same lobe, J Thorac Oncol. 11(7) 1090-1100, 2016.

Rosen J.E., Salazar M.C., Wang Z., Yu J.B., Decker R.H., Kim A.W., Detterbeck F.C., Boffa D.J., Lobectomy vs. stereotactic body radiotherapy in healthy patients with stage I lung cancer, J Thorac Cardiovasc Surg. 152(1) 44-54, 2016.

Rosen J.E., Salazar M.C., Dharmarajan, K., Kim A.W., Detterbeck F.C., Boffa D.J., Length of stay from the hospital perspective: practice of early discharge is not associated with increased readmission risk after lung cancer surgery, Annals of Surgery. Accepted – In Press, 2016.

Salazar M.C., Rosen J.E., Wang Z., Arnold B., Thomas D., Herbst R., Kim A.W., Detterbeck F.C., Blasberg J., Boffa D.J., Association of delayed adjuvant chemotherapy with survival after survival after lung cancer surgery, JAMA Oncology, 3(5) 610-619, 2017.

Boffa D.J., Rosen J.E., Mallin K., Loomis A., Gay G., Palis B., Thoburn K., Gress D., McKellar D.P., Shulman L.N., Facktor M.A., Winchester D.P., Using the national cancer database for outcomes research: a review, JAMA Oncology, Published online February 23, 2017.